What else must be done to end the drug-overdose epidemic
Overdose deaths have plateaued, but multiple policy barriers are holding back further progress. Lawmakers should follow the evidence on what works to save lives.
Related Articles
Tocilizumab Efficacy in Giant Cell Arteritis Phenotypes | RheumNow
A Spanish Collaborative Group study of Tocilizumab (TCZ) in Giant Cell Arteritis (GCA) demonstrated high efficacy regardless of the different vascular phenotypes treated. Multicentre study of…
Apple Reportedly Working on AirPods Pro 3 With Heart Rate Feature
Apple is working on a variety of health features for future AirPods, including heart rate monitoring and temperature sensing, according to…
Medications for alcohol‐use disorder and follow‐up after hospitalization for alcohol withdrawal: A multicenter study
Background Alcohol withdrawal is a common reason for admission to acute care hospitals. Prescription of medications for alcohol-use disorder (AUD) and close outpatient follow-up are…
Arizona School’s Curriculum Will Be Taught by AI, No Teachers
The state’s charter school board approved an application on Monday from Unbound Academy to open a school with a two-hour per day academic curriculum set…
FDA updates rules for which foods are ‘healthy,’ adding salmon and nuts and cutting sugary cereals
The updated definition allows more food to qualify as healthy, including higher fat fish, nuts, seeds, and certain oils.
Patients Couldn’t Pay Their Utility Bills. One Hospital Turned to Solar Power for Help. – KFF Health News
Doctors in Boston got tired of writing letters to utility companies asking for assistance for their medically vulnerable patients who need power and heat to…
Sepsis and Septic Shock | NEJM
Sepsis is a life-threatening, heterogeneous disorder involving a dysregulated immune response to infection. Research to identify subtypes and targeted therapies for host dysregulation is ongoing.
Cat themed fur-wrapped tri-mode keyboard now available for $240
Costs $239.00 USD, and an additional six models are planned for the future
Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer
This cross-sectional study evaluates trends and factors associated with selecting active surveillance or watchful waiting among individuals with intermediate-risk prostate cancer.
